NCT06716164 - Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

April 5, 2027

Conditions

Non-hodgkin Lymphoma,B Cell

Interventions

DRUG

Metabolically Armed CD19 CAR-T cells

Each subject receive metabolically armed CD19 CAR- T cells by intravenous infusion.

Trial Locations (1)

RECRUITING

The first affiliated hospital of medical college of zhejiang university, Hangzhou